News from the WV Board of Veterinary Medicine

News

  • Power Outage

    4/3/2024
    Due to power outage issues the WVBOP office will not be open today, April 3, 2024. The office will not be available by phone. All online submissions, applications and emails will continue to be processed by available staff working from home.We apologize for any inconvenience. We will reopen when the power is back on.
  • Drug Diversion Continuing Education Statement:

    3/24/2024
    The 2023 Legislature passed a law that will be implemented this renewal cycle (2024) for pharmacists regarding the Drug Diversion Continuing Education (CE) requirement.
  • UPDATED 5-2-23: WVBOP Statement on Semaglutide Compounding

    5/2/2023
    The West Virginia Board of Pharmacy (Board) staff has received inquiries concerning the compounding of semaglutide. This topic has become very prominent across the nation, as the medication has gained notoriety for various reasons. Semaglutide is, of course, a commercially available drug product marketed as Ozempic™ for treating diabetes and as Wegovy™ for weight loss. The Board of Pharmacy in both Mississippi and North Carolina have already issued statements, and the Boards of Pharmacy in other states appear ready to make similar statements.
  • WV BOP Statement on Semaglutide Compounding

    4/21/2023
    The West Virginia Board of Pharmacy (Board) staff has received inquiries concerning the compounding of semaglutide. This topic has become very prominent across the nation, as the medication has gained notoriety for various reasons. Semaglutide is, of course, a commercially available drug product marketed as OzempicTM for treating diabetes and as WegovyTM for weight loss. The Board of Pharmacy in both Mississippi and North Carolina have already issued statements, and the Boards of Pharmacy in other states appear ready to make similar statements. The federal Food Drug & Cosmetic Act prohibits pharmacies from compounding “drug products that are essentially copies of a commercially available drug product.” In general, compounding pharmacies may not compound semaglutide, a commercially available drug product.
Page Updated: 12:00:00 AM